Sections SEARCH Skip to content Skip to site index Log In Log In Today’s Paper DealBook | Pfizer to Merge Its Off-Patent Drug Unit With Mylan Advertisement DealBook Supported by ByKatie Thomas and Michael J. de la Merced Jul 29, 2019 Pfizer agreed on Monday to combine its off-patent drugs division, which sells treatments like the cholesterol drug Lipitor, with the pharmaceutical company Mylan, creating a potential powerhouse in the increasingly challenging business of producing generic medicines. The deal follows years of consolidation in the generic-drug industry and could spur more acquisitions, as companies struggle to maintain sales amid falling prices for their products. It’s a development that has been largely overlooked as consumers grapple with the escalating cost of branded treatments. Pfizer’s decision to combine the off-patent unit, Upjohn, with Mylan in an all-stock deal … [Read more...] about Pfizer to Merge Its Off-Patent Drug Unit With Mylan
Consumer price index netherlands
Sections SEARCH Skip to content Skip to site index Science Subscribe Log In Log In Today’s Paper Science | Why Would an Animal Trade One Body for Another? Advertisement Supported by matter Most species undergo metamorphosis, but scientists aren’t sure why the process evolved. One new theory: Metamorphosis gives animals greater access to food. ByCarl Zimmer March 25, 2019 As a child growing up in the Netherlands, Hanna ten Brink spent many days lingering by a pond in her family’s garden, fascinated by metamorphosis. Tadpoles hatched from eggs in the pond and swam about, sucking tiny particles of food into their mouths. After a few weeks, the tadpoles lost their tails, sprouted legs and hopped onto land, where they could catch insects with their new tongues. Eventually Dr. ten Brink became an evolutionary biologist. Now science has brought her back to that childhood fascination. Eighty percent … [Read more...] about Why Would an Animal Trade One Body for Another?